REBECCA RABINOWITZ: Open Payments
NPI 1487311593 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 39 payments from 13 companies in 2025. Trend: 2023 $1,724 · 2024 $1,246 · 2025 $1,626
Food & beverage: $1,626
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $414 |
| Alnylam Pharmaceuticals Inc. | 3 | $320 |
| Edwards Lifesciences Corporation | 2 | $224 |
| Abbott Laboratories | 2 | $199 |
| E.R. Squibb & Sons, L.L.C. | 6 | $113 |
| PFIZER INC. | 5 | $109 |
| Amgen Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| BridgeBio Pharma, Inc. | 2 | $43 |
Products named: AMVUTTRA, LOKELMA, WAINUA, CARDIOMEMS, SAPIEN 3 Ultra RESILIA, VYNDAQEL, EVOQUE, CAMZYOS.
Industry payments across CO — which companies pay providers there.
